Corecam AG’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,711
Closed -$239K 58
2026
Q1
$239K Buy
+1,711
New +$240K 0.2% 51

Other funds holding GILD

Corecam AG's GILD Position: Q2 2026 in Review

Corecam AG sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,711 shares — an estimated $239K sold.

Corecam AG first reported a position in GILD in Q1 2026 and held it in 1 quarter. The position peaked at $239K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Corecam AG reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Corecam AG sold 1,711 Gilead Sciences shares in Q2 2026, an estimated $239K.
  • Corecam AG first reported a position in Gilead Sciences in Q1 2026 and held it in 1 quarter.
  • Corecam AG's Gilead Sciences position peaked at $239K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Corecam AG's 13F filing for Q2 2026, filed 17 Jul 2026.